Pages that link to "Q72896468"

The following pages link to Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas (Q72896468):

Displaying 46 items.

• Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells (Q24301589) (← links)
• Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling (Q24319849) (← links)
• Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase (Q28286701) (← links)
• Hepatocyte growth factor is a mitogen for olfactory ensheathing cells (Q28366555) (← links)
• Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase (Q28588037) (← links)
• Hepatocyte growth factor, a versatile signal for developing neurons (Q33589398) (← links)
• Hepatocyte growth factor/scatter factor-induced intracellular signalling (Q33863966) (← links)
• Pathogenesis of hereditary tumors: beyond the "two-hit" hypothesis (Q34996618) (← links)
• Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors (Q35053276) (← links)
• Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma (Q35088274) (← links)
• Hepatocyte growth factor acts as a mitogen and chemoattractant for postnatal subventricular zone-olfactory bulb neurogenesis (Q35176949) (← links)
• Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components (Q35399426) (← links)
• The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis (Q36235637) (← links)
• MET and autism susceptibility: family and case-control studies (Q37201330) (← links)
• Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L (Q37709703) (← links)
• MET receptor tyrosine kinase as an autism genetic risk factor (Q38167461) (← links)
• Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors (Q38473715) (← links)
• Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury (Q39704002) (← links)
• Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB. (Q40122136) (← links)
• Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin. (Q40387762) (← links)
• CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. (Q40598012) (← links)
• Hepatocyte growth factor/scatter factor and the placenta (Q41055453) (← links)
• Schwann cell development, differentiation and myelination (Q41103197) (← links)
• Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo (Q42122433) (← links)
• Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. (Q42279434) (← links)
• Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. (Q42505785) (← links)
• Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons (Q43819365) (← links)
• Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins (Q43823567) (← links)
• Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: inflammatory cytokines. (Q44494766) (← links)
• Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line (Q44499856) (← links)
• Cooperative interaction of hepatocyte growth factor and neuregulin regulates Schwann cell migration and proliferation through Grb2-associated binder-2 in peripheral nerve repair (Q48103607) (← links)
• Neurotrophic effect of hepatocyte growth factor on neonatal facial motor neurons (Q48162053) (← links)
• Exogenous expression of hepatocyte growth factor (HGF) in rat striatum by naked plasmid DNA. (Q48393902) (← links)
• Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models (Q50026654) (← links)
• Response of Schwann cells to mitogens in vitro is determined by pre-exposure to serum, time in vitro, and developmental age (Q52193933) (← links)
• Hepatocyte Growth Factor (HGF) Promotes Peripheral Nerve Regeneration by Activating Repair Schwann Cells. (Q55334232) (← links)
• Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. (Q55477950) (← links)
• A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas (Q58543600) (← links)
• Effect of transforming growth factor-beta 1 and -beta 2 on Schwann cell proliferation on neurites (Q71891174) (← links)
• Rat oligodendroglia express c-met and focal adhesion kinase, protein tyrosine kinases implicated in regulating epithelial cell motility (Q73439485) (← links)
• cAMP-dependent protein kinase A is required for Schwann cell growth: Interactions between the cAMP and neuregulin/tyrosine kinase pathways (Q73629344) (← links)
• Co-expression of hepatocyte growth factor and its receptor in human prostate cancer (Q74433027) (← links)
• Expression of hepatocyte growth factor in primary sensory neurons of adult rats (Q77354626) (← links)
• Hepatocyte growth factor and the kidney: it is not just for the liver (Q77403442) (← links)
• Dynamic Plasticity of Axons within a Cutaneous Milieu (Q82296557) (← links)
• Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson’s disease (Q85006762) (← links)